AbbVie Inc. (ABBV) Social Stream
AbbVie Inc (ABBV) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AbbVie Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 13 | $140 | $118 | $128 | $163.75 | -21.83% |
| 2021-11-23 | 12 | $172 | $118 | $133.083 | $163.75 | -18.73% |
| 2022-01-03 | 13 | $172 | $118 | $135.538 | $163.75 | -17.23% |
| 2022-01-05 | 13 | $172 | $118 | $140.923 | $163.75 | -13.94% |
| 2022-01-14 | 13 | $172 | $118 | $143.416 | $163.75 | -12.42% |
| 2022-01-19 | 13 | $172 | $118 | $147.166 | $163.75 | -10.13% |
| 2022-02-01 | 13 | $172 | $133 | $149.916 | $163.75 | -8.45% |
| 2022-02-03 | 13 | $180 | $133 | $151.416 | $163.75 | -7.53% |
| 2022-02-14 | 13 | $180 | $133 | $153.5 | $163.75 | -6.26% |
| 2022-02-17 | 13 | $180 | $133 | $154.083 | $163.75 | -5.9% |
| 2022-03-08 | 14 | $180 | $133 | $153.538 | $163.75 | -6.24% |
| 2022-03-16 | 14 | $180 | $133 | $154.076 | $163.75 | -5.91% |
The Trend in the Analyst Price Target
Over the past 56 days, ABBV's average price target has gone up $6.91.
Over the past 135 days, ABBV's average upside potential has been 7.19%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-23 | 12 | 172 | 118 | 133.083 | 118.88 | 11.95% |
| 2021-12-09 | 13 | 172 | 118 | 135.538 | 124.15 | 9.17% |
| 2022-02-17 | 13 | 180 | 133 | 154.083 | 144.97 | 6.29% |
| 2022-02-28 | 14 | 180 | 133 | 153.538 | 147.77 | 3.9% |
| 2022-03-08 | 14 | 180 | 133 | 153.538 | 147.15 | 4.34% |
ABBV Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.64 | 9 | 1 | 4 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
ABBV's average broker recommendation rating worsened by 0.06 over the prior 120 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABBV as an investment opportunity.
- In the context of all US stocks, AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 89.85% of them.
- In the context of Pharmaceutical Products stocks, AbbVie Inc's average analyst price target is greater than 1530.25% of them.
- AbbVie Inc's number of analysts covering the stock is higher than 1496.85% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, AbbVie Inc's variance in analysts' estimates is lower than -330.46% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AbbVie Inc are TECH, SGEN, and RGEN.
Make investment decisions regarding ABBV using the data that counts. Try POWR Ratings for free.